Re-definition of claudin-low as a breast cancer phenotype
In breast cancer, the claudin-low breast cancer subtype is remarkably diverse. Here, the authors propose that claudin-low is not a classical intrinsic breast cancer subtype, but rather a complex additional phenotype that can occur across intrinsic subtypes.
Guardado en:
Autores principales: | Christian Fougner, Helga Bergholtz, Jens Henrik Norum, Therese Sørlie |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cda6d23debbe4bd5b9bd7b754c0eb7c2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comprehensive characterization of claudin-low breast tumors reflects the impact of the cell-of-origin on cancer evolution
por: Roxane M. Pommier, et al.
Publicado: (2020) -
Regulation of claudin/zonula occludens-1 complexes by hetero-claudin interactions
por: Barbara Schlingmann, et al.
Publicado: (2016) -
Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cells
por: Patrick D. Rädler, et al.
Publicado: (2021) -
Claudin-19 mutations and clinical phenotype in Spanish patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
por: Félix Claverie-Martín, et al.
Publicado: (2013) -
The tankyrase inhibitor G007-LK inhibits small intestine LGR5+ stem cell proliferation without altering tissue morphology
por: Norum,Jens Henrik, et al.
Publicado: (2018)